Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review

Affiliations

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
² Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Department of Public Health, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Medicine, St Luke's Roosevelt Hospital Center at Mount Sinai, New York, New York.
⁵ Section of Nephrology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut.

Ioannis Konstantinidis et al. JAMA Intern Med. 2016 Jan.

. 2016 Jan;176(1):121-4.

doi: 10.1001/jamainternmed.2015.6102.

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
² Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Department of Public Health, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Department of Medicine, St Luke's Roosevelt Hospital Center at Mount Sinai, New York, New York.
⁵ Section of Nephrology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut.

No abstract available

Comment in

Exclusion of Patients With Kidney Disease From Cardiovascular Trials.
Ishida JH, Johansen KL. Ishida JH, et al. JAMA Intern Med. 2016 Jan;176(1):124-5. doi: 10.1001/jamainternmed.2015.6403. JAMA Intern Med. 2016. PMID: 26618994 Free PMC article. No abstract available.
ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
Wyatt CM, Shineski M, Chertow GM, Bangalore S. Wyatt CM, et al. Kidney Int. 2016 Jun;89(6):1178-9. doi: 10.1016/j.kint.2016.03.012. Kidney Int. 2016. PMID: 27181770